John A. Howard,
Elizabeth E. Hood
Springer Berlin Heidelberg
e druk, 2016
9783662522950
Commercial Plant-Produced Recombinant Protein Products
Case Studies
Specificaties
Paperback, blz.
|
Engels
Springer Berlin Heidelberg |
e druk, 2016
ISBN13: 9783662522950
Rubricering
Onderdeel van serie
Biotechnology in Agriculture and Forestry
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts. There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically.
Specificaties
ISBN13:9783662522950
Taal:Engels
Bindwijze:paperback
Uitgever:Springer Berlin Heidelberg
Inhoudsopgave
<p>1 Introduction — Plant-produced protein products</p><p>Elizabeth E. Hood and Paul Christou</p><p>Part I: Highly Purified Proteins</p><p>2 Commercial Plant-Produced Recombinant Avidin</p><p>Elizabeth E. Hood and John A. Howard</p><p>3 Molecular farming in plants – the long road to the market</p><p>Rainer Fischer, Johannes F Buyel, Stefan Schillberg and Richard M Twyman</p><p>4 TrypZean™: an animal-free alternative to bovine trypsin</p><p>Aparna Krishnan, Susan L. Woodard</p><p>5 Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions </p><p>Gregory P. Pogue, Fakhrieh Vojdani, Kenneth E. Palmer, Earl White, Hugh Haydon, Barry Bratcher</p><p>Part II: Vaccines</p><p>6 Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice</p><p>Louis-P Vézina, Brian J Ward, Marc-André D’Aoust, Manon Couture, Sonia Trépanier, Andrew Sheldon1, Nathalie Landry</p><p>7 Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria</p><p>Stephen J. Streatfield, Natasha Kushnir, Vidadi Yusibov</p><p>8 An oral vaccine for TGEV immunization of pigs</p><p>Rajan, V.</p><p>9 Edible Rabies Vaccines</p><p>Elizabeth Loza-Rubio and Edith Rojas-Anaya</p><p>10 Newcastle disease vaccines</p><p>Miguel A. Gómez Lim</p><p>11 An oral vaccine for hepatitis B: challenges, setbacks, and breakthroughs</p><p>Celine A. Hayden</p><p>Part III: Industrial Proteins</p><p>12 Commercial Plant-Produced Recombinant Cellulases for Biomass Conversion</p><p>Elizabeth E. Hood, Deborah V. Requesens</p><p>13 Brazzein: A High Intensity Natural Sweetener</p><p>Gina Fake and John Howard</p><p>Part IV: Future Directions</p><p>14 The Future of Plant-Produced Pharmaceuticals and Industrial Proteins</p><p>John Howard, Elizabeth E. Hood</p><p>